4D Molecular Therapeutics, Inc.
FDMT
$6.65
$0.508.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.78% | -24.35% | -15.34% | -7.39% | 3.05% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -9.59% | 10.68% | 13.42% | -17.05% | 10.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -8.80% | -23.54% | -14.85% | -7.58% | 3.18% |
|
|
|||||
| Total Current Assets | -8.80% | -23.54% | -14.85% | -7.58% | 3.18% |
| Net Property, Plant & Equipment | -5.02% | -3.67% | -2.45% | 41.36% | -3.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 33.32% | 65.29% | 48.78% | 23.45% | 200.91% |
| Total Assets | -8.16% | -7.97% | -7.23% | -2.59% | -1.55% |
|
|
|||||
| Total Accounts Payable | 109.59% | -5.36% | 50.00% | -14.78% | -18.64% |
| Total Accrued Expenses | 18.43% | -14.13% | -11.89% | 67.62% | 41.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.74% | 0.75% | 10.72% | 59.29% | 0.72% |
| Total Finance Division Other Current Liabilities | 23.09% | 236.96% | 634.29% | -- | -- |
| Total Other Current Liabilities | 23.09% | 236.96% | 634.29% | -- | -- |
| Total Current Liabilities | 28.92% | -7.72% | -1.07% | 51.86% | 18.29% |
|
|
|||||
| Total Current Liabilities | 28.92% | -7.72% | -1.07% | 51.86% | 18.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.50% | -4.19% | -3.92% | 88.75% | -4.89% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -23.47% | -43.80% | -11.32% | -2.19% | -0.42% |
| Total Liabilities | 14.65% | -7.58% | -2.55% | 60.75% | 8.37% |
|
|
|||||
| Common Stock & APIC | 0.53% | 0.64% | 0.76% | 0.66% | 2.19% |
| Retained Earnings | -8.76% | -8.33% | -9.43% | -9.08% | -7.81% |
| Treasury Stock & Other | 1.51% | 44.98% | -78.78% | 468.26% | -168.81% |
| Total Common Equity | -10.40% | -8.01% | -7.66% | -6.02% | -2.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.40% | -8.01% | -7.66% | -6.02% | -2.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.40% | -8.01% | -7.66% | -6.02% | -2.03% |
|
|
|||||